Microbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 04, 2021
Share
Microbio Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 449.09 million compared to TWD 380.66 million a year ago. Revenue was TWD 459.29 million compared to TWD 387.51 million a year ago. Net income was TWD 19.22 million compared to TWD 554.59 million a year ago. Basic earnings per share from continuing operations was TWD 0.0365 compared to TWD 1.177 a year ago. Diluted earnings per share from continuing operations was TWD 0.0365 compared to TWD 1.177 a year ago.
For the nine months, sales was TWD 1,311.01 million compared to TWD 1,175.37 million a year ago. Revenue was TWD 1,339.04 million compared to TWD 1,195.84 million a year ago. Net loss was TWD 329.5 million compared to net income of TWD 2,465.93 million a year ago. Basic loss per share from continuing operations was TWD 0.6661 compared to basic earnings per share from continuing operations of TWD 5.1825 a year ago. Diluted loss per share from continuing operations was TWD 0.6661 compared to diluted earnings per share from continuing operations of TWD 5.1734 a year ago.
Microbio Co., Ltd. is a Taiwan-based company primarily engaged in the research, development, manufacture, distribution and wholesales of healthcare food products and pharmaceuticals. The Company provides fermentation products, including Tien Chun Bao (TCB) oral solutions; herbal products, including LeeHerb series products, as well as organic foods, including vegetables, fruits, nuts, pastry, seasonings, organic meals and others. In addition, it provides new medicines, including anticancer medicines, medicines for hepatitis, allergy, rheumatoid arthritis and others. The Company mainly distributes its products mainly within domestic market.
MICROBIO CO., LTD. 
